|
Volumn 98, Issue 7, 2006, Pages 435-
|
In U.S., biosimilars still await FDA decision.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
PHARMACOKINETICS;
UNITED STATES;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUGS, GENERIC;
HUMANS;
LEGISLATION, DRUG;
THERAPEUTIC EQUIVALENCY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 33645745278
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djj146 Document Type: Article |
Times cited : (4)
|
References (0)
|